-
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-09-28
The 2025 reference study identifies an RXRα/PPARγ/NEDD4 signaling axis through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of Smart-seq pathway discovery, molecular validation, and macrophage-specific RXRα knockdown provides a mechanistic framework for studying vascular senescence.
-
Phosbind Biotin LC: PVDF Phosphoprotein Workflow
2026-09-28
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes by Western Blot. It is suited to workflows using streptavidin-HRP and chemiluminescence, but not to water-only preparation or long-term storage of working solutions.
-
From DSS Injury to Epithelial Repair: A Translational Map
2026-09-27
DSS models are most informative when epithelial injury is paired with a plan to measure recovery. This article connects DSS colitis design with emerging GPR35–KLF5 repair biology, outlining practical strategies for reproducibility, mechanistic validation, and translational interpretation.
-
MLKL-Driven Lysosomal Permeabilization in Necroptosis
2026-09-26
Liu and colleagues identify a sequence in which activated MLKL polymerizes at lysosomal membranes, promotes lysosomal membrane permeabilization, and enables cathepsin B to contribute to necroptotic cell death. The study links organelle disruption to cell execution and offers experimental strategies for testing lysosomal protease involvement in regulated cell death.
-
T0070907: A PPARγ Antagonist for Causal Studies
2026-09-26
Use T0070907 to test whether PPARγ activity is necessary for transcriptional and inflammatory responses—not simply associated with them. This workflow connects the RXRα/PPARγ/NEDD4 findings in atherosclerotic foam cells to practical antagonist, reporter, and orthogonal-validation experiments.
-
NIR-Activated Co Single-Atom Enzyme for Cancer Therapy
2026-09-25
The study develops a near-infrared-triggered cobalt single-atom enzyme on hollow N-doped carbon spheres to combine photodynamic, photocatalytic, and photothermal effects. Its central contribution is a proposed strategy for amplifying reactive oxygen species activity while generating mild local hyperthermia, with the aim of improving tumor damage and preserving nearby tissue function.
-
Catalpol and Stroke Repair: From Cells to Circuits
2026-09-25
Catalpol (Catalpinoside) is examined here through a repair-centered lens: how neural stem cells and brain endothelial cells may coordinate recovery after ischemic injury. The analysis unpacks the SDF-1α/CXCR4 evidence and translates it into practical assay decisions for neuroprotection research.
-
HLY78 and Oral Fibrosis: Testing Wnt Causality
2026-09-24
HLY78 is a Wnt/β-catenin pathway modulator with a defined Axin–LRP6 mechanism. This article examines how that mechanism could help test pathway dependence in oral fibrosis research—and why developmental findings must not be mistaken for disease-model evidence.
-
MK-4827 (Niraparib) in PARP Inhibition Research
2026-09-24
MK-4827, also known as Niraparib, is a PARP-1/-2 inhibitor used to study DNA damage repair inhibition, especially in BRCA-mutant cancer models. A 2025 ovarian cancer study reports that all-trans retinoic acid reduced cisplatin-associated PARP inhibitor resistance in preclinical models, providing a resistance-focused context for niraparib research.
-
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-09-23
The reference study develops ICG-MOF-SS-AUNP12, a zirconium-based metal–organic framework that combines glutathione-responsive PD-1/PD-L1 blockade with near-infrared photothermal therapy. Its findings show how tumor-responsive release and local heat generation can be integrated with dendritic-cell and immune activation, while also highlighting the need to distinguish validated indocyanine green formulations from related infrared dyes.
-
Abiraterone Acetate in 3D Spheroid Models
2026-09-22
Explore how Abiraterone acetate can be evaluated in patient-derived prostate spheroids without conflating prodrug exposure with parent-drug biology. This evidence-led guide connects CYP17 inhibition, assay design, and translational interpretation for prostate cancer research.
-
Machine Learning Discovery of Senolytics
2026-09-22
The reference study shows that machine-learning models trained only on published screening data can identify senolytic candidates despite limited and heterogeneous datasets. Computational prioritization followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, offering a lower-cost framework for early-stage senolytic discovery and experimental follow-up.
-
Dyngo-4a for Dynamin-Dependent Endocytosis Studies
2026-09-21
Dyngo-4a turns dynamin-dependent membrane trafficking into a testable experimental variable for uptake, vesicle scission, and serial lipid nanoparticle workflows. This guide connects mechanistic endocytosis assays with the latest human T cell mRNA-engineering study while clearly separating established evidence from proposed applications.
-
PBS Liposomes for Macrophage Control
2026-09-21
PBS Liposomes provide a particle-matched negative control for separating clodronate-driven macrophage depletion from effects caused by liposome uptake or handling. This guide outlines comparative in vivo workflows, assay controls, protocol starting points, and troubleshooting strategies for more interpretable macrophage studies.
-
3-Deazaadenosine: Methylation and Antiviral Research
2026-09-20
3-Deazaadenosine is a S-adenosylhomocysteine hydrolase inhibitor that increases cellular SAH pressure and can suppress SAM-dependent methyltransferase activity. Its strongest use is preclinical pathway research, with reported in vitro and animal-model antiviral activity against Ebola and Marburg viruses, but it is not a clinical antiviral therapy.